Screener
Evommune EVMN Q4 2025 Annual earnings
Reported March 5, 2026 · Before market open
EPS-$1.43Miss by $0.61
EPS estimate-$0.82
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
Q3 2026-$0.85Miss by $0.02Q2 2026-$0.89Miss by $0.23Q1 2026-$0.64Beat by $0.19
Q4 2025-$1.43Miss by $0.61
Q3 2025-$8.07Miss by $1.99FAQ
- When did Evommune report Q4 2025 earnings?
- Evommune (EVMN) reported Q4 2025 earnings on March 5, 2026 before market open.
- What were Evommune's Q4 2025 revenue and EPS?
- Evommune reported eps of $-1.43 for Q4 2025.
- Did Evommune beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.82 by $0.61.
- Where can I find Evommune's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-093920) and the 10-K periodic report (0001193125-26-093932) directly on SEC EDGAR. The filing index links above go to sec.gov.
